NA Proactive news snapshot: Phunware, Harvest One Cannabis, LexaGene, Parallax Health Sciences – UPDATE … – Proactive Investors USA & Canada

susan ward Uncategorized 0

Phunware Inc (NASDAQ:PHUN) is launching an Initial Exchange Offering (IEO) for its own new currency called Phun tokens. The coin is designed to power the company’s Blockchain-Enabled Data Exchange and Mobile Loyalty Ecosystem which launched in June, allowing customers to unlock improved functionality and be rewarded for their engagement.

Harvest One Cannabis Inc (CVE:HVT) (OTCMKTS:HRVOF) is making inroads into the retail space as it revealed Burb, in which it owns a 20% stake, has been awarded its first two retail cannabis licences in Port Coquitlam, British Columbia. Burb has been operating stores as premium apparel and cannabis culture stores since April 20 this year  and it expects sales of cannabis products through its flagship store at 1502 Broadway Street in Port Coquitlam potentially as soon as September 21 this year

LexaGene Holdings Inc (CVE:LXG) (OTCMKTS:LXXGF) announced Thursday that a human clinical diagnostics laboratory reported successful results from beta testing using the company’s genetic analyzers. Assurance Scientific Laboratories in Alabama said that it had processed numerous urine samples that contained pathogens and found good correlation between LexaGene’s assay and its own process.

Parallax Health Sciences Inc (OTCMKTS:PRLX) announced Thursday it is purchasing a 19% stake in Global Career Networks Inc, a provider of career solutions to one of the largest recruiter networks in the world with exposure to over one-half million recruiters and millions of C-level executives.  By taking a minority stake in Global Career, the company is gaining access to a large population of professionals — namely doctors and other medical and healthcare providers — who may be interested in using Parallax’s Good Health Outcomes platform that allows users to remotely connect with their patients to monitor and respond to their conditions.

Salazar Resources Limited (CVE:ADZN) (OTCMKTS:ADVZF) announced Thursday that it had completed its first helicopter-supported airborne survey over the Curipamba project in Ecuador. The survey was conducted with Salazar’s partner Adventus Mining Corporation (CVE:ADZN) (OTCMKTS:ADVZF), which has a 75% interest in the coper-gold project. Curipamba covers 21,537 hectares in the province of Bolivar. Historical work on the project uncovered the high-grade El Domo volcanic massive sulphide deposit in addition to other areas of mineralization

Alchemist Mining Inc (CSE:AMS) stands to receive a C$3.5 million injection from a real estate investment company. Pedro Villagran-Garcia, CEO of Dinatrum/Alumifuel Power Corporation (OTCMKTS:AFPW), said in a statement Thursday that he has made the investment proposal to Alchemist. According to Dinatrum, Alchemist will issue 14 million post-consolidation shares at C$0.25 per unit. Each unit consists of one share and one warrant exercisable at C$0.60 with a two-year expiration. Dinatrum said it has made the commitment to invest in Alchemist so that it can capitalize on the real estate opportunities available to it through Alchemist in California and the US.

Ceylon Graphite Corp (CVE:CYL) (OTCMKTS:CYLYF) unveiled plans on Thursday to raise up to C$1.25 million via a private placing and its intention to amend convertible debentures it issued last year. In the placing, the group plans to issue units at C$0.08 a throw. Each unit will consist of one share of Ceylon Graphite and one whole warrant. Each warrant entitles the bearer to buy one company share for C$0.15 for two years from the date of issue

Hill Street Beverage Company Inc (TSXV:BEER) (OTCMKTS:HSEEF) said Thursday that CEO Terry Donnelly will make the company’s investment case at the two-day Extraordinary Future Conference in Vancouver.   In a statement, the company said Donnelly will present Hill Street’s investment thesis at 10:20 am Pacific Time on September 22, at Workshop Stage 1 at the Vancouver Convention Centre West.

Medallion Resources Ltd (CVE:MDL) (TCMKTS:MMLOF) announced Thursday that CEO Donald Lay sold 2.55 million shares of the company’s stock and subsequently subscribed to 2.55  million units in the first tranche of the company’s private placement. Each unit contains one share at a price of $0.105 — the same price Lay sold the bulk of his shares for — and one half warrant. Whole warrants are exercisable to acquire shares at a price of $0.165. All told, Lay now controls 3.8 million shares, 3.6 million warrants and 1.2 million stock options, good for 8.6% of the company.

HighGold Mining Inc, which is being spun-out of Constantine Metal Resources Ltd (CVE:CEM), has closed a non-brokered private placement of 17 million units at a price of C$0.45 per unit for gross proceeds of C$7.65 million. The money will be used to fund exploration and development of HighGold’s mineral properties, as well as for general working capital and other corporate purposes.

European High Growth Opportunities Securitization Fund has confirmed the conversion of an additional $100,000 of its aggregate debentures in Braingrid Limited (CSE:BGRD) on August 28, 2019 and September 10, 2019 and the sale of an aggregate 930,000 shares in the company between September 16, 2019 and September 18, 2019. Under a financing arrangement, Braingrid last month issued a convertible debenture to the fund in the principal amount of $850,000 and share purchase warrants exercisable to acquire up to 14,875,000 common shares of the company.  After the conversions and the sale of shares, European High Growth Opportunities Securitization Fund now owns or controls, directly or indirectly. debentures, shares and warrants representing 33.21% of Braingrid’s issued and outstanding common shares on a non-diluted basis, and 25.63% on a partially-diluted basis.

CB2 Insights (CSE:CBII) (OTCMKTS:CBIIF), the medical cannabis data group, revealed it had increased its market presence in the UK, saying it will license its technology to MyAccess Clinics (MAC) to manage their patient data. The latter operates multiple clinics in the UK and is focused on providing care for patients with unmet needs, which licensed medicines have failed to address.

Avalon GloboCare Corp (NASDAQ:AVCO) announced Thursday it has initiated its first-in-human Phase I clinical trial of its flagship AVA-001 therapy in China to treat relapsed/refractory B-cell malignancies, including B-cell lymphoblastic leukemia and non-Hodgkin’s Lymphoma. The clinical trial of AVA-001, which is a leverage individualized CAR (Chimeric Antigen Receptor) T-cell therapy candidate for immuno-oncology, is being conducted at the Hebei Yanda Lu Daopei Hospital and Beijing Lu Daopei Hospital in China, the world’s single largest CAR-T treatment network with over 600 patients. CAR-T cells are engineered to express a receptor that recognizes a specific cancer surface target to attack.

AIM ImmunoTech Inc (NYSEAmerican:AIM) announced Thursday that the US Department of Defense has granted a four-year, $6.42 million “Breakthrough Award” to the Roswell Park Comprehensive Cancer Center for a clinical study on a combination of therapies, including the company’s drug Ampligen, in patients with brain-metastatic breast cancer (BMBC). In a statement, the company said the funding is through the DoD’s breast cancer research program, which started the Breakthrough Awards to support research that has the potential to end breast cancer. The Phase II trial, slated to kick off in 2020, will be the first clinical study to assess the effectiveness of a three-pronged strategy combining distinct immunotherapy approaches:

Capstone Turbine Corporation (NASDAQ:CPST) continues to convert major oil and gas customers using its clean-energy microturbines to long-term service contracts. The company on Thursday announced that Cal Microturbine, its exclusive distributor for California, Idaho, Oregon, and Washington, has signed a Factory Protection Plan (FPP) long-term service contract covering 2 megawatts of its microturbines installed at a single location in California.

NexTech AR Solutions (CSE:NTAR) (OTCMKTS:NEXCF) is tapping the services of a Hollywood veteran to lead the augmented reality company’s foray into the entertainment business. The New York- and Toronto-based company has hired Dr Barry Sandrew to take on the chief operating officer and executive producer role of AR Studios, which produces immersive augmented reality (AR) content. Sandrew brings three decades worth of founding and leading visual effects production studios in Hollywood and has worked on 65 of the highest-grossing 3D feature films released over the past ten years.

LexaGene Holdings Inc (CVE:LXG) (OTCMKTS:LXXGF) announced Thursday that a human clinical diagnostics laboratory reported successful results from beta testing using the company’s genetic analyzers. Assurance Scientific Laboratories in Alabama said that it had processed numerous urine samples that contained pathogens and found good correlation between LexaGene’s assay and its own process. Human clinical diagnostics is the next milestone in Massachusetts-based LexaGene’s pathogen-screening technology, which is currently being commercialized for veterinary medicine as well as agricultural industries.

Weekend Unlimited Inc (CSE:POT) (OTCMKTS:WKULF), revealed Thursday that it is entering the hemp-derived CBD space with its WKND! Wellness product line, which will soon be available online and for retail sales in the United States. In a statement, the Vancouver-based lifestyle-focused cannabis company said it was in “final development” mode for its WKND! Wellness Line product line.

Millennial Lithium Corp (CVE:ML) (OTCQB:MLNLF) is making good progress at the Pastos Grandes project in Argentina and expects to start treating brine at its pilot plant in December this year to produce battery-grade lithium carbonate. In a wide-ranging update on Thursday, the company revealed current work at the site in Salta province, included ongoing liming and feeding of brine to pilot ponds, the building of the pilot plant and an additional long-term pumping well test.

The Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCMKTS:TGODF) is hosting site visits for analysts this week at its facilities to show off the depth of its certified organic cannabis production. The company said in a statement Thursday that it expects to welcome 25 analysts from Canada and the US to its facilities in Hamilton, Ontario and Valleyfield, Quebec on Thursday and Friday.

XPhyto Therapeutics Corp (CSE:XPHY) is bringing in a global cannabis consultant to design its cannabis facility in Germany.  In a press release Thursday, the company announced a two-year European consulting deal with international cannabis expert Stephen Schroeder to commission what it’s calling “The Bunker,” a top-notch hydroponics and extraction facility.

Duos Technologies Group, Inc. (OTCMKTS:DUOT),  a provider of intelligent security analytical technology solutions, has announced that it will be exhibiting at the 59th Annual Railway Interchange 2019, which is being held on September 22-24 in Minneapolis. Scott Carns, Duos executive vice president and interim COO said: “Exhibiting at the RSSI conference is a tremendous opportunity for Duos to raise our profile within the rail community and get our solutions in front of relevant industry personnel who understand the value our technology holds.”

1933 Industries Inc (CSE:TGIF) (OTCMKTS:TGIFF) has signed a 12-month licensing agreement with PLUGplay, a manufacturer of magnetic cannabis vaporizer cartridges. Under the terms of the deal announced Thursday, 1933 subsidiary Alternative Medicine Association will manufacture distillate and vape pens under the PLUGplay brand to distribute in Nevada.

1933 Industries also said its board of directors has approved the issue of bonus shares to its chairman, Brayden Sutton, and its chief executive officer, Christopher Rebentisch, under their respective employment contracts. The group added that Sutton will receive 291,901 shares and Rebentisch will receive 175,913 shares, all of which will be issued at a deemed price of $0.365 per share. The company further announced that, under the amended terms of two consulting agreements, it will also be issuing 650,000 share purchase warrants, in lieu of cash consideration, entitling the holder to purchase one common share at a price of $0.37 exercisable in whole or in part until June 13, 2022. The group said the bonus shares and the warrants will be subject to a four month regulatory hold period.

Royal Nickel Corp (CSE:RNX) said the Toronto Stock Exchange has noted that the company will list an additional 45 million shares at the open on September 20, 2019, as well as 22.5 million warrants – trading under the symbol RNX.WT – after its recent public offering. As stated in its short form prospectus, dated September 17, 2019, the company is issuing  45 million units at 40 cents per unit under the offering which it expects to close before the open on September 20. Each unit will consist of one share and one-half warrant, with each whole warrant being exercisable at 50 cents per share until 5 pm Toronto time on the date that is 24 months following the closing date of the offering.

Medexus Pharmaceuticals Inc. (CVE:MDP) (OTCMKTS:PDDPF) announced that voting results from its Annual Meeting of Shareholders, held on September 18, 2019 in Toronto, saw each of its director nominees elected by a show of hands with over a 99% share. It added that each of the other matters put forward before shareholders for consideration and approval at the meeting, as described in the management information circular, was duly approved by the requisite number of votes.


« »